ANAB
Price:
$56.07
Market Cap:
$2.42B
AnaptysBio, Inc. is a biotechnology firm currently in the clinical development phase, dedicated to pioneering novel therapeutic agents aimed at treating inflammatory conditions and immuno-oncological diseases. The company's portfolio features several promising drug candidates. These include Imsidolimab, an antibody designed to block the interleukin-36 receptor (IL-36R), targeting diverse skin-related inflammatory disorders. Another key program is Rosnilimab, an anti-PD-1 agonist antibody, which works by enhancing PD-1 signaling to mitigate human inflammatory diseases driven by T-cells. Furthermore, ANB032, an anti-BTLA modulator antibody, addresses human inflammatory conditions linked to imb...[Read more]
Industry
Biotechnology
IPO Date
2017-01-26
Stock Exchange
NASDAQ
Ticker
ANAB
According to AnaptysBio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.45B. This represents a change of 199.56% compared to the average of 816.79M of the last 4 quarters.
The mean historical Enterprise Value of AnaptysBio, Inc. over the last ten years is 469.23M. The current 2.45B Enterprise Value has changed 52.04% with respect to the historical average. Over the past ten years (40 quarters), ANAB's Enterprise Value was at its highest in in the March 2018 quarter at 1.60B. The Enterprise Value was at its lowest in in the September 2016 quarter at -12279120.00.
Average
469.23M
Median
431.66M
Minimum
-7544790.00
Maximum
1.26B
Discovering the peaks and valleys of AnaptysBio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 229.62%
Maximum Annual Enterprise Value = 1.26B
Minimum Annual Increase = -16821.71%
Minimum Annual Enterprise Value = -7544790.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 674.06M | 35.63% |
| 2024 | 497.00M | 35.67% |
| 2023 | 366.32M | -30.89% |
| 2022 | 530.03M | 229.62% |
| 2021 | 160.80M | 13.94% |
| 2020 | 141.12M | 12.96% |
| 2019 | 124.93M | -86.77% |
| 2018 | 944.00M | -25.18% |
| 2017 | 1.26B | -16821.71% |
| 2016 | -7544790.00 | -57.75% |
The current Enterprise Value of AnaptysBio, Inc. (ANAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
512.46M
5-year avg
445.64M
10-year avg
469.23M
AnaptysBio, Inc.’s Enterprise Value is greater than Xencor, Inc. (1.08B), greater than Oculis Holding AG (442.29M), greater than Phathom Pharmaceuticals, Inc. (812.47M), greater than Mind Medicine (MindMed) Inc. (2.44B), greater than UroGen Pharma Ltd. (1.53B), greater than Nurix Therapeutics, Inc. (1.46B), greater than BridgeBio Oncology Therapeutics Inc. (570.82M), greater than Kodiak Sciences Inc. (1.79B), less than Dianthus Therapeutics, Inc. (2.80B), greater than Taysha Gene Therapies, Inc. (985.42M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.08B | $914.17M | |
| 442.29M | $634.01M | |
| 812.47M | $827.07M | |
| 2.44B | $1.56B | |
| 1.53B | $1.45B | |
| 1.46B | $1.47B | |
| 570.82M | $620.83M | |
| 1.79B | $1.80B | |
| 2.80B | $3.43B | |
| 985.42M | $1.43B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnaptysBio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AnaptysBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AnaptysBio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for AnaptysBio, Inc. (ANAB)?
What is the 3-year average Enterprise Value for AnaptysBio, Inc. (ANAB)?
What is the 5-year average Enterprise Value for AnaptysBio, Inc. (ANAB)?
How does the current Enterprise Value for AnaptysBio, Inc. (ANAB) compare to its historical average?